AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
On 3 Jun 2009, Dainippon Sumitomo Pharma Co Ltd announced that positive results from a phase 2 clinical trial for lurasidone in the treatment of patients with schizophrenia have been published in The Journal of Clinical Psychiatry. This six-week, randomized, double-blind, multicentre, placebo-controlled trial, involving 180 patients with acute schizophrenia, evaluated a single fixed dose of …